{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihnu74sxzro7dkbfvpusoat24emlugqbjelzoajuwe3o7kkjjsenq",
    "uri": "at://did:plc:rw25qu4iizzqb7mvgkjsxfj4/app.bsky.feed.post/3mhtpawioscn2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifiq2kqyccny5xslhhnjgmjvvwrpzf2cvudrvhzl3awcblgqe5kuq"
    },
    "mimeType": "image/jpeg",
    "size": 16587
  },
  "path": "/p/lyme-disease-vaccine-demonstrated",
  "publishedAt": "2026-03-24T20:38:50.000Z",
  "site": "https://outbreaknewstoday.substack.com",
  "textContent": "Biotech companies, Valneva and Pfizer, announced Monday topline results from the Phase 3 VALOR “Vaccine Against Lyme for Outdoor Recreationists” clinical trial of its investigational 6-valent OspA-based Lyme disease vaccine candidate PF-07307405 (LB6V, formerly known as VLA15) demonstrating:",
  "title": "Lyme disease vaccine demonstrated more than 70% efficacy in preventing disease"
}